We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Creating More Potent Vaccines
News

Creating More Potent Vaccines

Creating More Potent Vaccines
News

Creating More Potent Vaccines

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Creating More Potent Vaccines "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The new insight gets researchers one step closer to developing vaccines that could be more protective against some of the most intractable viral infections, including HIV and flu.

For the study researchers Brian Laidlaw, Dr. Joseph Craft, and Dr. Susan M. Kaech and co-authors observed immune responses to infection in mouse models. They found that a chemical signal known as IL-10, which is secreted by regulatory T cells, is important for the development of long-term immunity.

IL-10 is particularly important for keeping inflammation in check during the resolution phase of infection. By reducing inflammation during this phase, IL-10 enabled long-term memory cells — CD8+ T cells — to mature and develop their capacity to protect against future infection.

The finding may hold the key to more effective vaccines. “A critical problem with many vaccines is that they do not elicit a robust and protective T cell response,” said Laidlaw. The study sheds light on another pathway for enhancing the body’s protective response.  “By understanding this process, during each phase of the immune response, we hope to be able to mirror these steps in a vaccine approach,” he said.

Advertisement